1. Home
  2. GRDN vs DOLE Comparison

GRDN vs DOLE Comparison

Compare GRDN & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRDN
  • DOLE
  • Stock Information
  • Founded
  • GRDN 2004
  • DOLE 1851
  • Country
  • GRDN United States
  • DOLE Ireland
  • Employees
  • GRDN N/A
  • DOLE N/A
  • Industry
  • GRDN Retail-Drug Stores and Proprietary Stores
  • DOLE Farming/Seeds/Milling
  • Sector
  • GRDN Consumer Staples
  • DOLE Consumer Staples
  • Exchange
  • GRDN Nasdaq
  • DOLE Nasdaq
  • Market Cap
  • GRDN 1.6B
  • DOLE 1.3B
  • IPO Year
  • GRDN 2024
  • DOLE 2021
  • Fundamental
  • Price
  • GRDN $20.13
  • DOLE $14.03
  • Analyst Decision
  • GRDN Strong Buy
  • DOLE Buy
  • Analyst Count
  • GRDN 2
  • DOLE 3
  • Target Price
  • GRDN $24.50
  • DOLE $16.67
  • AVG Volume (30 Days)
  • GRDN 416.9K
  • DOLE 589.3K
  • Earning Date
  • GRDN 08-15-2025
  • DOLE 08-13-2025
  • Dividend Yield
  • GRDN N/A
  • DOLE 2.42%
  • EPS Growth
  • GRDN N/A
  • DOLE N/A
  • EPS
  • GRDN N/A
  • DOLE 0.99
  • Revenue
  • GRDN $1,282,307,000.00
  • DOLE $8,453,373,000.00
  • Revenue This Year
  • GRDN $12.01
  • DOLE $3.87
  • Revenue Next Year
  • GRDN $2.33
  • DOLE $1.93
  • P/E Ratio
  • GRDN N/A
  • DOLE $14.13
  • Revenue Growth
  • GRDN 19.55
  • DOLE 0.91
  • 52 Week Low
  • GRDN $14.16
  • DOLE $11.88
  • 52 Week High
  • GRDN $26.91
  • DOLE $17.12
  • Technical
  • Relative Strength Index (RSI)
  • GRDN N/A
  • DOLE 49.70
  • Support Level
  • GRDN N/A
  • DOLE $13.60
  • Resistance Level
  • GRDN N/A
  • DOLE $14.25
  • Average True Range (ATR)
  • GRDN 0.00
  • DOLE 0.26
  • MACD
  • GRDN 0.00
  • DOLE 0.02
  • Stochastic Oscillator
  • GRDN 0.00
  • DOLE 66.16

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

About DOLE Dole plc

Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.

Share on Social Networks: